References
1. Centers for Disease Control and Prevention. Health Department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. (2022). URL: https://www.cdc.gov/mis-c/cases/index.html (date of access January 2022).
2. Boldyreva M.N. SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections. Immunologiya. 2019; 41 (3): 197–205. DOI: https://www.doi.org/10.33029/0206-4952-2020-41-3-197-205 (in Russian)
3. Grazioli S., Tavaglione F., Torriani G., Wagner N., Rohr M., L’Huillier A.G., Leclercq C., Perrin A., Bordessoule A., Beghetti M., Schmid J.P., Vavassori S., Perreau M., Eberhardt C., Didierlaurent A., Kaiser L., Eckerle I., Roux-Lombard P., Blanchard-Rohner G. Immunological Assessment of Pediatric Multisystem Inflammatory Syndrome Related to Coronavirus Disease 2019. Journal of the Pediatric Infectious Diseases Society. 2021; 10 (6): 706–13. PIMD: 33180935.
4. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395 (10237): 1607–8. DOI: https://www.doi.org/10.1016/S0140-6736(20)31094-1
5. Verdoni L., Mazza A., Gervasoni A., Martelli L., Ruggeri M., Ciuffreda M., Bonanomi E., D’Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; 395 (10239): 1771–8. DOI: https://www.doi.org/10.1016/S0140-6736(20)31103-X
6. Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. 2020. URL: https://emergency.cdc.gov/han/2020/han00432.asp (date of access January 2022).
7. World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. 2020. URL: https://www.who.int/publications-detail/multisysteminflammatorysyndrome-in-children-and-adolescents-with-covid19 (date of access January 2022).
8. Rodionovskaya S.R., Mazankova L.N., Osmanov I.M., Samitova E.R., Antsupova M.A., Koroid V.V., Kaurova E.P. New coronavirus infection as trigger factor for multisystem inflammatory syndrome in children: literature review and analysis of original data. Pediatria. 2020; 99 (6): 127–34. DOI: https://www.doi.org/10.24110/0031-403X-2020-99-6-127-134 (in Russian)
9. Levi H., Paemel R.V., Filomeen H. Multisystem inflammatory syndrome in children related to COVID-19: A systematic review. European journal of pediatrics. 2021; 180 (7): 2019–34. DOI: https://www.doi.org/10.1007/s00431-021-03993-5
10. Vella L.A., Giles J.R., Baxter A.E., Oldridge D.A., Diorio C., Kuri-Cervantes L., Pampena M.B., Wu J.E., Chen Z., Huang Y.J., Anderson E.M., Gouma S., Mcnerney K.O., Chase J., Burudpakdee C., Lee J.H., Apostolidis S.A., Huang A.C., Mathew D., Kuthuru O., Goodwin E.C., Weirick M.E., Bolton M.J., Arevalo C.P., Ramos A., Jasen C.J., Conrey P.E., Sayed S., Giannini H.M., D’andrea K., Meyer N.J., Behrens E.M., Bassiri H., Hensley S.E., Henrickson S.E., Teachey D.T., Betts M.R., Wherry E.J. Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Science immunology. 2021; 6 (57): eabf7570. DOI: https://www.doi.org/10.1126/sciimmunol.abf7570
11. Consiglio C. R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., Santilli V., Campbell T., Bryceson Y., Eriksson D., Wang J., Marchesi A., Lakshmikanth T., Campana A., Villani A., Rossi P., CACTUS Study Team. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020; 183 (4): 968–81.e7. PIMD: 32966765.
12. Kabeerdoss J., Pilania R.K., Karkhele R., Kumar T.S., Danda D., Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatology international. 2021; 41 (1): 19–32. DOI: https://www.doi.org/10.1007/s00296-020-04749-4
13. Henderson L.A., Yeung R.S.M. MIS-C: early lessons from immune profiling. Nat Rev Rheumatol. 2021; 17 (2): 75–6. DOI: https://www.doi.org/10.1038/s41584-020-00566-y
14. Ouldali N., Toubiana J., Antona D., Javouhey E., Madhi F., Lorrot M., Leger P-L., Galeotti C., Claude C., Wiedemann A., Lachaume N., Ovaert C., Dumortier M., Kahn J.-E., Mandelcwajg A., Percheron L., Biot B., Bordet J., Girardin M.-L., Yang D.D., Grimaud M., Oualha M., Allali S., Bajolle F., Beyler C., Meinzer U., Levy M., Paulet A.-M., Levy C., Cohen R., Belot A., Angoulvant F., French Covid-19 Paediatric Inflammation Consortium. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. Jama. 2021; 325 (9): 855–64. PIMD: 33523115.
15. Vardhana S.A., Wolchok J.D. The many faces of the anti-COVID immune response. J. Exp. Med. 2020; 217 (6): e20200678. PIMD: 32353870.
16. Diorio C., Henrickson S.E., Vella L.A., McNerney K.O., Chase J., Burudpakdee C., Lee J.H., Jasen C., Balamuth F., Barrett D.M., Banwell B.L., Brent K.M., Baltz A.M., Chiotos K., Fisher B.T., Fitzgerald J.C., Gerber J.S., Gollomp K., Gray C., Grupp S.A., Harris R.M., Kilbaugh T.J., John A.R.O., Lambert M., Leibling E.J., Paessler M.E., Petrosa W., Phillips C., Reilly A.F., Romberg N.D., Seif A., Sesok-Pizzini D.A., Sullivan K.E., Vardaro J., Behrens E.M., Teachey D.T., Bassiri H. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2. The Journal of clinical investigation. 2020; 130 (11): 5967–75. DOI: https://www.doi.org/10.1172/JCI140970
17. Henderson L.A., Canna S.W., Friedman K.G., Gorelik M., Lapidus S.K., Bassiri H., Behrens E.M., Ferris A., Kernan K.F., Schulert G.S., Seo P., Son M.B.F., Tremoulet A.H., Yeung R.S.M., Mudano A.S., Turner A.S., Karp D.R., Mehta J. J. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2. Arthritis & Rheumatology. 2021; 73 (4): e13–e29. PMID: 33277976.
18. Capone C.A., Subramony A., Sweberg T., Schneider J., Shah S., Rubin L., Schleien C., Epstein S., Johnson J.C., Kessel A., Misra N., Mitchell E., Palumbo N., Rajan S., Rocker J., Williamson K., Davidson K.W., Northwell Health COVID-19 Research Consortium. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. The Journal of pediatrics. 2020; 224: 141–5. PMID: 32553873.
19. Kabeerdoss J., Pilania R. K., Karkhele R., Kumar T.S., Danda D., Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatology international. 2020; 41 (1): 19–32. DOI: https://www.doi.org/10.1007/s00296-020-04749-4
20. Esteve-Sole A., Anton J., Pino-Ramírez R.M., Sanchez-Manubens J., Fumadó V., Fortuny C., Rios-Barnes M., Sanchez-de-Toledo J., Girona-Alarcon M., Mosquera J.M., Ricart S., Launes C., Fernandez de Sevilla M., Jou C., Munoz-Almagro C., Gonzalez-Roca E., Vergara A., Carillo J., Juan M., Cuadras D., Noguera-Julian A., Jordan I., Alsina L. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease. The Journal of Clinical Investigation. 2021; 131 (6): e144554. DOI: https://www.doi.org/10.1172/JCI144554
21. Godfred-Cato S., Bryant B., Leung J., Oster M.E., Conklin L., Abrams J., Roguski K., Wallace B., Prezzato E., Koumans E.H., Lee E.H., Geevarughese A., Lash M.K., Reilly K.H., Pulver W.P., Thomas D., Feder K.A., Hsu K.K., Plipat N., Richardson G., Reid H., Lim S., Schmitz A., Pierce T., Hrapcak S., Datta D., Morris S.B., Clarke K., Belay E., Team C. M. C. R. COVID-19-associated multisystem inflammatory syndrome in children—United States, March–July 2020. Morbidity and Mortality Weekly Report. 2020; 69 (32): 1074. DOI: https://www.doi.org/10.15585/mmwr.mm6932e2
22. Rowley A.H., Shulman S.T., Arditi M. Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children. The Journal of clinical investigation. 2020; 130 (11): 5619–21. DOI: https://www.doi.org/10.1172/JCI143840
23. Martinez O.M., Bridges N.D., Goldmuntz E., Pascual V. The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges. Nature Medicine. 2020; 26 (12): 1819–24. DOI: https://www.doi.org/10.1038/s41591-020-1140-9
24. Costagliola G., Spada E., Consolini R. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. Immunity, Inflammation and Disease. 2021; 9 (2): 331–9. DOI: https://www.doi.org/10.1002/iid3.404
25. Low D.E. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Critical care clinics. 2013; 29 (3): 651–75. DOI: https://www.doi.org/10.1016/j.ccc.2013.03.012
26. Cheng M.H., Zhang S., Porritt R.A., Rivas M.N., Paschold L., Willscher E., Binder M., Arditi M., Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proceedings of the National Academy of Sciences. 2020; 117 (41): 25254–62. DOI: https://www.doi.org/10.1073/pnas.2010722117
27. Carter M.J., Fish M., Jennings A., Doores K.J., Wellman P., Seow J., Acors S., Graham C., Timms E., Kenny J., Neil S., Malim M.H., Tibby S.M., Shankar-Hari M. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nature medicine. 2020; 26 (11): 1701–7. DOI: https://www.doi.org/10.1038/s41591-020-1054-6
28. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210. DOI: https://www.doi.org/10.33029/0206-4952-2021-42-3-198-210. (in Russian)
29. Juzhaninova S.V., Sajdakova E.V. The phenomenon of immune exhaustion. Achievements of modern biology. 2017; 137 (1): 70–83. (in Russian)
30. Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., Singh A.R., Li S., Tarquinio K.M., Jaggi P., Oster M.E., Zackai S.P., Gillen J., Ratner A.J., Walsh R.F., Fitzgerald J.C., Keenaghan M.A., Alharash H., Doymaz S., Clouser K.N., Giuliano Jr. J.S., Gupta A., Parker R.M., Maddux A.B., Havalad V., Ramsingh S., Bukulmez H., Bradford T.T., Smith L.S., Tenforde M.W., Carroll C.L., Riggs B.J., Gertz S.J., Daube A., Lansell A., Coronado Munoz A., Hobbs C.V., Marohn K.L., Halasa N.B., Patel M.M., Randolph A. G. Multisystem inflammatory syndrome in US children and adolescents. New England Journal of Medicine. 2020; 383 (4): 334–46. DOI: https://www.doi.org/10.1056/NEJMoa2021680
31. Shatokhina E.A., Polonskaia A.S., Mershina Е.А., Seredenina Е.М., Plisyuk А.G., Georginova О.А., Krasnova T.N., Pavlikova E.P., Orlova Ya.А., Sinitsyn V.E., Kruglova L.S., Kamalov A.A. Possible role of anti-IL17 drugs in the management of COVID-19 – our own experience and literature review. Immunologiya. 2021; 42 (3): 243–53. DOI: https://www.doi.org/10.33029/0206-4952-2021-42-3-243-253. (in Russian)